Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
Grosche, J., Kettenmann, H
For most Tirzepatide stacking protocols, I recommend injectable secretagogues like CJC-1295 and Ipamorelin over MK-677
VITAMIN B12- cyanocobalamin injection, solution MWI/Vet One Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA
Kennedy Jr., an advisory panel to the Food and Drug Administration recommended on Thursday that compounding pharmacies be allowed to manufacture the drugs BPC-157, KPV, TB-500, and MOTS-c